Obestatin
Obestatin has been studied in 3 papers since 2016: 1 observational study in people, 1 in animals, 1 review. The newest paper, Jan 10, 2024: “Unlocking the Potential of Obestatin: A Novel Peptide Intervention for Skeletal Muscle Regeneration and Prevention of Atrophy”.
3 papers study it10 findingsUpdated
At a glance
The findings reach people, from one lab or study. 2 independent labs in 2 countries.
“For each ng/ml increase in obestatin levels, the odds for diminished appetite was 0.75 (95% CI: 0.59-0.96).”
2 of its findings point the other way.
- 2 independent labs in 2 countries
- 2 findings against
- Funder: European Society for Clinical Nutrition and Metabolism
- Humans1
- Animals1
What did studies of obestatin find?
8Studies of obestatin measured 8 outcomes, among them PAX7, skeletal muscle regeneration and muscular atrophy.
PAX7
upin reviews1
1 study
PAX7
upin reviews1
Obestatin increases PAX7 (required for muscle stem cell mobilisation).
“obestatin also works by inducing the transcription of Pax7”
Reviewrequired for muscle stem cell mobilisation
Molecular biotechnology
Skeletal muscle regeneration
upin reviews1
1 study
Skeletal muscle regeneration
upin reviews1
Obestatin improves skeletal muscle regeneration.
“effect of obestatin on skeletal muscle regeneration is similar to that of ghrelin”
Review
Molecular biotechnology
Muscular atrophy
downin reviews1
1 study
Muscular atrophy
downin reviews1
Obestatin prevents muscular atrophy.
“obestatin can be purposed as a peptide intervention to prevent skeletal muscle wasting and induce myogenesis”
Review
Molecular biotechnology
Protein-energy wasting
no changein humans1OR 1.26
1 study
Protein-energy wasting
no changein humans1OR 1.26
Obestatin was not clearly linked with protein-energy wasting in humans after adjustment for lean body mass (OR 1.26 (95% CI 0.83-1.91)).
“after lean body mass (LBM) was added to this model, the association between obestatin and malnutrition was abolished (OR: 1.26, 95% CI: 0.83-1.91)”
Humansafter adjustment for lean body mass
European journal of clinical nutrition
Diminished appetite
no changein humans1
1 study
Diminished appetite
no changein humans1
Obestatin was not clearly linked with diminished appetite in humans (patients 71 years and older).
“However, these associations were not observed in patients 71 years and older.”
Humanspatients 71 years and older
European journal of clinical nutrition
Testosterone
upin chickens1
1 study
Testosterone
upin chickens1
Obestatin increases testosterone in ovarian fragments of fasted hens.
“In ovarian fragments of fasted hens it reduced E, promoted T, and did not influence P and AVT release.”
Animalsin ovarian fragments of fasted hensovarian fragments
The role of metabolic state and obestatin in control of chicken ovarian hormone release
Poultry science
Arginine vasotocin
upin chickens1
1 study
Arginine vasotocin
upin chickens1
Obestatin increases arginine vasotocin in ad libitum fed chicken ovarian tissue.
“promoted AVT, and did not alter P and T release by ovarian tissue isolated from ad libitum fed chicken.”
Animalsin ad libitum fed chicken ovarian tissueovarian fragments
The role of metabolic state and obestatin in control of chicken ovarian hormone release
Poultry science
Estradiol
downin chickens1
1 study
Estradiol
downin chickens1
Obestatin decreases estradiol in ad libitum fed chicken ovarian tissue.
“Obestatin addition reduced E, promoted AVT, and did not alter P and T release by ovarian tissue isolated from ad libitum fed chicken.”
Animalsin ad libitum fed chicken ovarian tissueovarian fragments
The role of metabolic state and obestatin in control of chicken ovarian hormone release
Poultry science
What is obestatin linked with?
2Studies link obestatin with 2 measures: protein-energy wasting and diminished appetite.
Protein-energy wasting
upin humans1OR 1.51
1 study
Protein-energy wasting
upin humans1OR 1.51
Obestatin is linked with a higher risk of protein-energy wasting in humans (patients 71 years and older; logistic models including appetite) (OR 1.51 (95% CI 1.05-2.18)).
“showed increasing odds for PEW (defined by ESPEN consensus-based criteria for the diagnosis of malnutrition) across increasing serum obestatin levels”
Humanspatients 71 years and older; logistic models including appetite
European journal of clinical nutrition
Diminished appetite
downin humans1OR 0.75
1 study
Diminished appetite
downin humans1OR 0.75
Obestatin is linked with a lower risk of diminished appetite in humans (patients younger than 71 years; adjusted for lean body mass, IL-6 and acyl-ghrelin) (OR 0.75 per ng/ml (95% CI 0.59-0.96)).
“For each ng/ml increase in obestatin levels, the odds for diminished appetite was 0.75 (95% CI: 0.59-0.96).”
Humanspatients younger than 71 years; adjusted for lean body mass, IL-6 and acyl-ghrelin
European journal of clinical nutrition